Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
出版年份 2021 全文链接
标题
Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 27, Issue 6, Pages 513-522
出版商
Baishideng Publishing Group Inc.
发表日期
2021-02-05
DOI
10.3748/wjg.v27.i6.513
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
- (2020) Ting Zhang et al. Protein & Cell
- Methamphetamine-induced alterations in intestinal mucosal barrier function occur via the microRNA-181c/ TNF-α/tight junction axis
- (2019) Simin Shen et al. TOXICOLOGY LETTERS
- Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?
- (2018) Michael F. Vaezi et al. Clinical Gastroenterology and Hepatology
- Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
- (2018) Yuji Naito et al. DIGESTION
- Pathophysiology of Gastroesophageal Reflux Disease
- (2018) Jan Tack et al. GASTROENTEROLOGY
- Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit
- (2018) Jaspreet Suri et al. MEDICINE
- Microbiota transplantation: concept, methodology and strategy for its modernization
- (2018) Faming Zhang et al. Protein & Cell
- The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
- (2018) Benjamin H. Mullish et al. JOURNAL OF HOSPITAL INFECTION
- On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
- (2018) Zubair Khan et al. Gastroenterology Research and Practice
- Proton Pump Inhibitor–Refractory Gastroesophageal Reflux Disease
- (2018) Rena Yadlapati et al. MEDICAL CLINICS OF NORTH AMERICA
- Fecal microbiota transplantation for patients with irritable bowel syndrome
- (2018) Wenting Wen et al. MEDICINE
- The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
- (2017) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Long-term proton pump inhibitors and risk of gastric cancer development after treatment forHelicobacter pylori: a population-based study
- (2017) Ka Shing Cheung et al. GUT
- World Gastroenterology Organisation Global Guidelines
- (2017) Richard Hunt et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass
- (2017) Zhi He et al. Scientific Reports
- Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up
- (2017) Chao Ding et al. Gastroenterology Report
- The natural history of gastro-esophageal reflux disease: a comprehensive review
- (2016) E. Savarino et al. DISEASES OF THE ESOPHAGUS
- Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis
- (2016) Hong-chang Li et al. PANCREATOLOGY
- Proton pump inhibitors affect the gut microbiome
- (2015) Floris Imhann et al. GUT
- Proton pump inhibitors alter the composition of the gut microbiota
- (2015) Matthew A Jackson et al. GUT
- Fecal Microbiota Transplantation in Inflammatory Bowel Disease
- (2014) Gianluca Ianiro et al. MEDICINE
- Molecular Pathways: Pathogenesis and Clinical Implications of Microbiome Alteration in Esophagitis and Barrett Esophagus
- (2012) L. Yang et al. CLINICAL CANCER RESEARCH
- Role of E-cadherin in the Pathogenesis of Gastroesophageal Reflux Disease
- (2011) Biljana Jovov et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease
- (2010) Y. Kinoshita et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started